Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02853305 |
|---|---|
| Brief Title: | Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361) |
| First Submitted : | July 29, 2016 |
| First Submitted that Met QC Criteria : | July 29, 2016 |
| First Posted : | August 2, 2016 (Estimate) |
| Results First Submitted : | April 28, 2021 |
| Results First Submitted that Met QC Criteria : | April 28, 2021 |
| Results First Posted : | May 20, 2021 |
| Last Update Submitted that Met QC Criteria : | August 14, 2023 |
| Last Update Posted : | September 8, 2023 |